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Conclusion: The Orbit I study demonstrates that the OAS offers a safe and effective
method to debulk calcified coronary lesions which continues positive post-procedure.
A new, multicenter, prospective IDE trial (Orbit II) is underway in the U.S. to obtain
further data on the safety and effectiveness of the OAS in severely calcified coronary
lesions.
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Background: Lipid-rich coronary plaques (LCPs) develop during atherosclerosis
progression and underlie most acute coronary syndromes. Recently, a new near-infrared
spectroscopy intravascular system (NIRS) for LCP detection was developed. Since the
natural history of atherosclerosis progression and coronary LCP formation is difficult
to assess in humans, studies in large animal models of atherosclerosis are essential.
We investigated coronary atherosclerosis development in a diseased porcine model by
intracoronary imaging with the NIRS.
Methods: 15 male swine were fed an atherogenic diet for 15 months (M). Serial NIRS
intracoronary imaging was performed at 9, 12 and 15M follow-up (FU); the vascular
segments were matched at the three FU times using side-branches as landmarks (LM,
Fig.).
Results: Data show that the lipid core burden index (LCBI) increases from 9±3A.U.
at 9M to 20±10 respectively 45±28 at 12 and 15M FU (Fig, yellow shows detected
lipid in the vessel wall). The maximal LCBI (corresponding to the worst 10mm within
the imaged segment) indicating the most important LCP also increased from 61±19 at
9M to 114±50 resp. 160±72 at 12 and 15M. Furthermore, the distribution of LCP
probability along the vascular segment increased from distal towards proximal in all
three coronaries.
Conclusion: In conclusion, serial NIRS imaging was able to detect changes in LCP
during disease progression in coronary arteries of atherosclerotic swine. The LCPs
were detected at regions prone to LCP development as acknowledged in humans.
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Background: Our study aims to evaluate the success of rotational atherectomy with a
modified protocol using a platform speed of 135 krpm, pecking technique and a step-
up burr sizing up to a debulking burr-to-artery ratio of greater than 0.6 relative to
conventional stenting procedures without atherectomy by comparing overall long time
survival.
Methods: Out of a 5 year period we selected all 1033 patients treated with single vessel
intervention. 144 cases were excluded because of incomplete data sets. Propensity-
score matching based on 26 clinical and angiographic variables was used to reduce
treatment-selection bias for rotational atherectomy resulting in the formation of 279
matched pairs (i.e. 578 patients). To compare long time survival up to 80 months
Kaplan Mayer curves were calculated.
Results: With respect to postprocedural variables Non-Rota and Rota patients did not
differ significantly regarding final lumen diameter, stent length, number of stents,
percentage of DES and IVUS. Significant differences were found regarding lumen
gain (p=0.009) and percentage of GPIIb/IIIa receptor blocker treatment. Long term
overall survival plots demonstrate a significant advantage for the Rota group (p<0.01)
with a hazard ratio of 0.52 (CI 0.32–0.85). Multivariate Cox regressions showed that
this advantage is not due to differences in GP IIb/IIIa blocker treatment.
Conclusion: With our redefined protocol of rotational atherectomy we could reduce
long-term mortality for matched pairs by 48% on average. We explain this result by
the less traumatizing atherectomy procedure compared to previous trials and the greater
lumen increase assuming a better stent apposition.
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Background: Stent underexpansion is a risk factor for in-stent restenosis (ISR) and
stent thrombosis. Existing techniques to optimize stent expansion are often ineffective
and can be harmful. Implantation of a second stent within an underexpanded stent is
unlikely to correct what is a primary mechanical problem, leading to recurrent
presentations with ISR.
Methods: This study aimed to clarify the effectiveness and feasibility of Excimer Laser
Coronary Angioplasty (ELCA) in improving stent expansion when high pressure non-
compliant balloon (NCB) inflation was ineffective. ECLA ablation was performed at
high energy during contrast injection and only within the under-expnaded stent. The
primary endpoint of optimal stent dilatation was defined as successful stent expansion
using the same NCB which had been unsuccessful prior to ECLA. Secondary endpoints
were the composite of all-cause death, myocardial infarction (MI) and target lesion
revascularization (TLR) at 6-months and defined as Major Adverse Cardiac Events
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